Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Escitalopram for the Treatment of Depression in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE4
PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effect of NeuroAD on the Cognitive Function of Alzheimer Patients
- Status
- COMPLETED
- Phase
- NA
Effect of NeuroAD on Alzheimer Patients
- Status
- COMPLETED
- Phase
- NA
The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease
- Status
- UNKNOWN
- Phase
- N/A
Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment Project
- Status
- COMPLETED
- Phase
- NA
Bexarotene Amyloid Treatment for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Pathway for Alzheimer's Disease in China (CPAD)
- Status
- COMPLETED
- Phase
- N/A
The Role of Mid-Life Adiposity in Functional Brain Connectivity
- Status
- TERMINATED
- Phase
- N/A
Central and Systemic Inflammation in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of MT-4666
- Status
- COMPLETED
- Phase
- PHASE2
Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).
- Status
- UNKNOWN
- Phase
- NA
Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements
- Status
- COMPLETED
- Phase
- N/A
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3